<sentence id="0">Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells .</sentence>
<sentence id="1">RATIONALE : Neointimal hyperplasia contributes to atherosclerosis and restenosis after percutaneous coronary intervention .</sentence>
<sentence id="2">Vascular injury in each of these conditions results in the release of mitogenic growth factors and hormones that contribute to pathological vascular smooth muscle cell growth and inflammation .</sentence>
<sentence id="3">Hepatocyte growth factor ( HGF ) is known as an antiinflammatory growth factor , although it is downregulated in injured tissue .</sentence>
<sentence id="4">However , <scope type="spec" id="0"> the precise mechanism how HGF reduces inflammation is <cue type="spec" id="0">unclear</cue></scope> .</sentence>
<sentence id="5">OBJECTIVE : To elucidate the mechanism how HGF and its receptor c-Met reduces angiotensin II ( Ang II ) -induced inflammation .</sentence>
<sentence id="6">METHODS AND RESULTS : HGF reduced Ang II-induced vascular smooth muscle cell growth and inflammation by controlling translocation of SHIP2 ( Src homology domain 2-containing inositol 5'-phosphatase 2 ) , which led to Ang II-dependent degradation of epithelial growth factor receptor .</sentence>
<sentence id="7">Moreover , the present study also revealed a preventive effect of HGF on atherosclerotic change in an Ang II infusion and cuff HGF transgenic mouse model .</sentence>
<sentence id="8">CONCLUSIONS : These data <scope type="spec" id="1"> <cue type="spec" id="1">suggest</cue> that the HGF/c-Met system <scope type="spec" id="2"> <cue type="spec" id="2">might</cue> regulate extrinsic factor signaling that maintains the homeostasis of organs</scope></scope> .</sentence>